Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-06 Purchase(A) |
2023-02-17 4:19 pm |
Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr |
5,714 | $7 | $39,998 | 22,679 (Direct) |
View |
| 2023-02-06 Purchase(A) |
2023-02-17 4:17 pm |
Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer |
14,285 | $7 | $99,995 | 49,933 (Direct) |
View |
| 2023-02-13 Purchase |
2023-02-15 6:32 pm |
Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director |
10,072 | $7.1972 | $72,490 | 1,664,702 (Indirect) |
View |
| 2023-02-09 Purchase |
2023-02-13 4:04 pm |
Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director |
400 | $7.25 | $2,900 | 1,654,630 (Indirect) |
View |
| 2023-02-03 Purchase |
2023-02-09 4:36 pm |
Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director |
311,078 | $7.103 | $2,209,588 | 1,654,230 (Indirect) |
View |
| 2023-02-06 Purchase |
2023-02-08 7:40 pm |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) |
View |
| 2023-02-06 Purchase |
2023-02-08 7:32 pm |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) |
View |
| 2023-02-06 Purchase |
2023-02-08 6:29 pm |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.P. HEALY JAMES Katabi Maha Sofinnova Management X-A L.L.C. 10% Owner |
285,714 | $7 | $1,999,998 | 3,467,156 (Direct) |
View |
| 2022-02-06 Purchase |
2023-02-08 4:05 pm |
Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr |
5,714 | $7 | $39,998 | 22,679 (Direct) |
View |
| 2022-02-06 Purchase |
2023-02-08 4:04 pm |
Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer |
14,285 | $7 | $99,995 | 54,933 (Indirect Direct) |
View |
| 2022-12-16 Sale |
2022-12-19 5:01 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
2,212 | $19.49 | $43,116 | 62,622 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 4:08 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
19,711 | $18.26 | $359,973 | 177,961 (Direct) |
View |
| 2022-12-07 Sale |
2022-12-08 4:06 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
494 | $16.47 | $8,136 | 26,821 (Direct) |
View |
| 2022-11-17 Sale |
2022-11-21 4:08 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
3,289 | $15.85 | $52,128 | 75,045 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-10 4:04 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
494 | $16.54 | $8,171 | 27,315 (Direct) |
View |
| 2022-10-18 Sale |
2022-10-20 4:37 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
8,590 | $19.41 | $166,735 | 162,845 (Direct) |
View |
| 2022-10-05 Sale |
2022-10-06 4:04 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
988 | $21.64 | $21,380 | 27,809 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:05 pm |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
32,000 | $20.9 | $668,773 | 2,093,797 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-22 4:06 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
16,840 | $20.72 | $348,944 | 262,914 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-14 4:12 pm |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
22,363 | $21.16 | $473,236 | 1,160,362 (Direct) |
View |
| 2022-09-09 Sale |
2022-09-13 4:04 pm |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
29,022 | $20.43 | $592,812 | 2,200,436 (Direct) |
View |
| 2022-09-07 Sale |
2022-09-09 4:23 pm |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
21,891 | $20.37 | $445,879 | 2,264,306 (Direct) |
View |
| 2022-09-07 Sale |
2022-09-08 4:41 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
988 | $18.63 | $18,406 | 28,797 (Direct) |
View |
| 2022-09-01 Sale |
2022-09-06 4:29 pm |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
34,196 | $21.09 | $721,236 | 2,310,078 (Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:15 pm |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
8,539 | $19.13 | $163,389 | 294,798 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-19 4:39 pm |
Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
9,925 | $20.25 | $201,026 | 2,960,231 (Indirect) |
View |
| 2022-08-12 Sale |
2022-08-15 4:11 pm |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
20,528 | $20.16 | $413,799 | 1,224,084 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-15 Option Award |
2023-02-17 4:14 pm |
N/A 2033-02-14 |
Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:12 pm |
N/A 2033-02-14 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:10 pm |
N/A 2033-02-14 |
Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:08 pm |
N/A 2033-02-14 |
Vera Therapeutics Inc. | VERA | Lin Celia Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:05 pm |
N/A 2033-02-14 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
450,000 | $0 | 450,000 (Direct) |
View |
Ownership |
2023-02-08 7:21 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner |
0 | $0 | 1,714,285 (Indirect) |
View |
| 2022-12-16 Exercise |
2022-12-19 5:01 pm |
N/A 2030-12-15 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
2,212 | $0 | 62,622 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-19 5:01 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
2,212 | $2.8968 | 62,622 (Direct) |
View |
| 2022-12-13 Exercise |
2022-12-14 4:08 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
1,078 | $6.3728 | 177,961 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 4:08 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
19,711 | $0 | 177,961 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 4:08 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
18,633 | $11 | 177,961 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:08 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
1,078 | $6.3728 | 75,045 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:08 pm |
N/A 2030-03-31 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
3,289 | $0 | 75,045 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:08 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
2,211 | $2.8968 | 75,045 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 4:06 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
5,153 | $2.3174 | 1,134,031 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 4:06 pm |
N/A 2030-01-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
65,153 | $0 | 1,134,031 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 4:06 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
60,000 | $2.8968 | 1,134,031 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 4:37 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
1,078 | $6.3728 | 162,845 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 4:37 pm |
N/A 2030-03-31 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
8,590 | $0 | 162,845 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 4:37 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
2,212 | $2.8968 | 162,845 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 4:37 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
5,300 | $11 | 162,845 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 4:05 pm |
N/A 2030-12-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
32,000 | $0 | 2,093,797 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 4:05 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
32,000 | $2.8968 | 2,093,797 (Direct) |
View |
| 2022-09-20 Exercise |
2022-09-22 4:06 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
1,078 | $6.3728 | 262,914 (Direct) |
View |
| 2022-09-20 Exercise |
2022-09-22 4:06 pm |
N/A 2030-03-31 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
16,840 | $0 | 262,914 (Direct) |
View |
| 2022-09-20 Exercise |
2022-09-22 4:06 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
2,162 | $2.8968 | 262,914 (Direct) |
View |
| 2022-09-20 Exercise |
2022-09-22 4:06 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
13,600 | $11 | 262,914 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-14 4:12 pm |
N/A 2030-12-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
22,363 | $0 | 1,160,362 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-14 4:12 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
22,363 | $2.8968 | 1,160,362 (Direct) |
View |
| 2022-09-09 Exercise |
2022-09-13 4:04 pm |
N/A 2030-12-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
29,022 | $0 | 2,200,436 (Direct) |
View |
| 2022-09-09 Exercise |
2022-09-13 4:04 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
29,022 | $2.8968 | 2,200,436 (Direct) |
View |
| 2022-09-07 Exercise |
2022-09-09 4:23 pm |
N/A 2030-12-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
21,891 | $0 | 2,264,306 (Direct) |
View |
| 2022-09-07 Exercise |
2022-09-09 4:23 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
21,891 | $2.8968 | 2,264,306 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-06 4:29 pm |
N/A 2030-12-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
34,196 | $0 | 2,310,078 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-06 4:29 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
34,196 | $2.8968 | 2,310,078 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:15 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
12,500 | $0 | 294,798 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 4:15 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
1,078 | $6.3728 | 294,798 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 4:15 pm |
N/A 2030-03-31 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
8,539 | $0 | 294,798 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 4:15 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
2,161 | $2.8968 | 294,798 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 4:15 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
5,300 | $11 | 294,798 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:11 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Lin Celia Chief Medical Officer |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:08 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr |
15,000 | $0 | 16,148 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:06 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer |
33,750 | $0 | 40,268 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:03 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
43,750 | $0 | 181,150 (Direct) |
View |
| 2022-08-17 Exercise |
2022-08-19 4:39 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
9,925 | $0 | 2,960,231 (Indirect) |
View |
| 2022-08-17 Exercise |
2022-08-19 4:39 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
9,925 | $11 | 2,960,231 (Indirect) |
View |
| 2022-08-12 Exercise |
2022-08-15 4:11 pm |
N/A 2030-12-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
20,528 | $0 | 1,224,084 (Direct) |
View |
| 2022-08-12 Exercise |
2022-08-15 4:11 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
20,528 | $2.8968 | 1,224,084 (Direct) |
View |
Ownership |
2022-08-11 4:52 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
0 | $0 | 2,970,156 (Indirect) |
View |